FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/086318 [Registered on: 05/05/2025] Trial Registered Prospectively
Last Modified On: 03/05/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A Randomized Controlled Trial to Assess the Efficacy of Deep Tissue Heating in Patients with Severe Diabetic Foot Ulcers 
Scientific Title of Study   An Open-Label Add-On Randomized Controlled Trial to Assess the Efficacy of Deep Tissue Heating as an Adjuvant Therapy in Patients with Severe Diabetic Foot Ulcers 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Subhasish Sarkar 
Designation  Assistant Professor 
Affiliation  College of Medicine and Sagore Dutta Hospital 
Address  Department of General Surgery OPD, Room No. 2. College of Medicine and Sagore Dutta Hospital. 578 B. T. Road, Kamarhati, Kolkata

North Twentyfour Parganas
WEST BENGAL
700058
India 
Phone  9564524882  
Fax    
Email  s.sarkar735@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Subhasish Sarkar 
Designation  Assistant Professor 
Affiliation  College of Medicine and Sagore Dutta Hospital 
Address  Department of General Surgery OPD, Room No. 2. College of Medicine and Sagore Dutta Hospital. 578 B. T. Road, Kamarhati, Kolkata


WEST BENGAL
700058
India 
Phone  9564524882  
Fax    
Email  s.sarkar735@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Subhasish Sarkar 
Designation  Assistant Professor 
Affiliation  College of Medicine and Sagore Dutta Hospital 
Address  Department of General Surgery OPD, Room No. 2. College of Medicine and Sagore Dutta Hospital. 578 B. T. Road, Kamarhati, Kolkata


WEST BENGAL
700058
India 
Phone  9564524882  
Fax    
Email  s.sarkar735@gmail.com  
 
Source of Monetary or Material Support  
College of Medicine and Sagore Dutta Hospital. 578 B. T. Road, Kamarhati, Kolkata, West Bengal, India 
 
Primary Sponsor  
Name  College of Medicine and Sagore Dutta Hospital 
Address  578 B. T. Road, Kamarhati, Kolkata - 700058, West Bengal 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Subhasish Sarkar  College of Medicine and Sagore Dutta Hospital  General Surgery OPD Room No. 2. B. T. Road, Kamarhati, Kolkata - 700058, West Bengal
North Twentyfour Parganas
WEST BENGAL 
9564524882

s.sarkar735@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, CMSDH  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E116||Type 2 diabetes mellitus with other specified complications,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Microwave Diathermy  2,450 megahertz Microwave Diathermy intended to produce a therapeutic heat 1 to 2 cm below the skin within specific volumes of the body through the transcutaneous transmission of high frequency electromagnetic (EM) energy. Duration of intervention in each session will be 15 seconds cycle for 10 minutes. Intervention will be given twice weekly in OPD clinic of the hospital. The add on therapy will be continued till healthy granulation is seen on the ulcer wound bed.  
Comparator Agent  Standard Wound Management  Dressing and debridement of wounds using gauge and saline. Medications as and when required. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Individuals with diabetic foot ulcers. 
 
ExclusionCriteria 
Details  Individuals with severe comorbidities. 
 
Method of Generating Random Sequence   Stratified randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improved healing rate, healing time, infection rate, amputation rate.  Weekly monitoring from baseline. Comparison every 4 weeks.  
 
Secondary Outcome  
Outcome  TimePoints 
Wound healing rate, infection rate, amputation rate, all cause mortality.  Baseline, 8 Weeks, 6 months.  
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   19/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  19/05/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The standard treatment guidelines for the prevention and management of diabetic foot include conventional treatments such as infection management and surgical interventions. Improvement of blood blow rates in the affected peripheral tissues of the body improves the accessibility of drugs and tissue repair proteins and potentially reduces the wound healing time. This adjuvant therapy would potentially provide a faster therapeutic solution for DFUs.

 
Close